Stockholders’ Deficit - Schedule of Stock Options Roll Forward (Details) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jul. 31, 2024 USD ($) $ / shares shares	Jan. 31, 2024 USD ($) $ / shares shares
Number of Options
Outstanding, beginning of period (in shares) | shares	3,185,020
Granted (in shares) | shares	8,000,000
Exercised (in shares) | shares	(680,400)
Cancelled (in shares) | shares	(18,226)
Outstanding, end of period (in shares) | shares	10,486,394	3,185,020
Options vested, number of options (in shares) | shares	2,402,223
Options exercisable, number of options (in shares) | shares	2,402,223
Weighted- Average Exercise Price
Outstanding, beginning of period (in USD per share) | $ / shares	$ 6.23
Granted (in USD per share) | $ / shares	32.00
Exercised (in USD per share) | $ / shares	5.46
Cancelled (in USD per share) | $ / shares	17.84
Outstanding, end of period (in USD per share) | $ / shares	25.92	$ 6.23
Options vested, weighted average exercise price per share (in USD per share) | $ / shares	5.88
Options exercisable, weighted average exercise price per share (in USD per share) | $ / shares	$ 5.88
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Options outstanding, weighted average remaining contractual term	8 years 3 months 18 days	4 years 2 months 12 days
Options vested, weighted average remaining contractual term	3 years 4 months 24 days
Options exercisable, weighted average remaining contractual term	3 years 4 months 24 days
Options outstanding, aggregate intrinsic value | $	$ 118,297	$ 71,347
Options exercised, aggregate intrinsic value | $	17,800
Options exercisable, aggregate intrinsic value | $	75,249
Options vested, aggregate intrinsic value | $	$ 75,249